Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
AACR, ACS, addressed, adequacy, Amgen, ample, antitumor, arising, begun, behavior, billable, billed, bioprocessing, Biotest, bloodstream, bond, broader, BZL, chemotherapeutic, compatibility, constitute, context, contrast, correction, Corticosteroidi, creation, Cripto, currency, depletion, derecognition, Diosynth, disadvantage, distinction, disulfide, electricity, enjoyed, EORTC, error, feasibility, Global, inconclusive, integrin, Italiana, justify, largest, likelihood, modification, mortality, NCI, necessitate, opportunity, ordinary, Organisation, preparatory, prompting, pronouncement, reassessment, recaptured, recordkeeping, recurrence, reliance, replaced, residual, resolved, rollforward, routine, RTP, SAR, seasoned, sequentially, SICOR, situation, Societ, step, stimulation, substitute, tabular, thereof, thioether, threshold, translation, tubulin, twelve, unrecognized, unrecorded, Unregistered, wholly, window, yield
Removed:
activated, active, aggressive, amounted, Assistant, ATI, attaching, attack, background, belonging, bid, billion, biochem, biochemical, Biochemistry, biomedical, body, build, caution, chemically, chemotherapy, Combinatorial, combined, combining, commonly, conjugating, Connecticut, consuming, conversion, converted, cooperatively, delivered, detached, detailed, diagnostic, discovering, dividing, efficient, elicit, engineered, England, entirety, eradicated, estimating, exploiting, facilitate, feed, final, finalized, Finally, forma, generation, GlaxoSmithKline, growing, HuCAL, identifying, inactive, incomplete, innovative, intent, invested, Jen, John, joined, joining, Kellogg, lack, Lambert, led, leverage, Library, lifetime, LINKAGE, linked, London, marker, measure, Median, Medicine, minimally, necessarily, Northwestern, open, operated, originally, path, Pathology, Pauline, payload, Pennsylvania, pharmacology, Philadelphia, physiological, pilot, play, pleasure, point, powerful, pro, Professor, promise, properly, protein, pursuing, radiation, radiotherapy, range, rapid, refine, regain, register, rejoined, relapse, release, released, reliable, relinquish, represented, repurchase, repurchased, resale, resemble, residing, resistance, resurfacing, Ryan, School, Science, scientist, served, settle, shared, Shire, specificity, structured, subjective, subscription, successor, suggested, surface, Surgery, Taxol, Temple, terminating, tested, tolerable, toxic, toxicology, traded, transferable, unilaterally, University, unmet, unwanted, validate, validated, validation, vehicle, worked, written, Xenogen, Zurich
Filing tables
Filing exhibits
Related press release
IMGN similar filings
Filing view
External links
EXHIBIT 23
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statements (Form S-3 Nos. 333-02441, 333-07661, 333-15819, 333-22153, 333-31795, 333-48042, 333-48385, 333-57234 and 333-100123 and Form S-8 Nos. 333-122553, 333-41534, 333-73544, 333-47543, 333-53292, 333-75372 and 333-75374) of ImmunoGen, Inc. and in the related Prospectuses of our reports dated August 24, 2006, with respect to the consolidated financial statements and schedule of ImmunoGen, Inc., ImmunoGen, Inc. management's assessment of the effectiveness of internal control over financial reporting, and the effectiveness of internal control over financial reporting of ImmunoGen, Inc., included in the Annual Report (Form 10-K) for the year ended June 30, 2006.
/s/ Ernst & Young LLP
Boston, Massachusetts
August 24, 2006